1171044-18-0

Usage

Uses

Used in Medicinal Chemistry:
(4-Isopropyl-piperazin-1-yl)-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-methanone is used as a building block or intermediate for the synthesis of pharmaceutical compounds, particularly those targeting the central nervous system. Its unique structure may allow for the development of novel drugs with improved efficacy and reduced side effects.
Used in Boron-based Chemistry:
In the field of boron-based chemistry, (4-Isopropyl-piperazin-1-yl)-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-methanone is used as a precursor for the creation of boron-containing molecules with potential applications in various industries, such as electronics, energy storage, and advanced materials.
Used in Materials Science:
(4-Isopropyl-piperazin-1-yl)-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-methanone may be utilized as a component in the development of new materials with specific properties, such as improved thermal stability, chemical resistance, or electrical conductivity, depending on the final application in various industries.

Upstream product

• 4318-42-7 1-(1-methylethyl)piperazine 
• 180516-87-4 4-carboxyphenylboronic acid pinacol ester 
• 586-76-5 4-Bromobenzoic acid 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 1171040-52-0 [4-(6'-isopropylamino-[2,2';4',3]terpyridin-5-yl)-phenyl]-(4-isopropyl-piperazin-1-yl)-methanone 
• 1171041-88-5 [4-(6'-hydroxy-6-methyl-[2,2';4',3]terpyridin-5-yl)-phenyl]-(4-isopropyl-piperazin-1-yl)-methanone 
• 1172114-13-4 (4-(5-bromopyridin-3-yl)phenyl)-(4-isopropylpiperazin-1-yl)-methanone 

Relevant academic research and scientific papers

PYRROLO[3,2-C]PYRIDINE DERIVATIVES AS TLR INHIBITORS

The present invention provides a heterocyclic compound having a TLR7, TLR9, TLR7/8, TLR7/9 or TLR7/8/9 inhibitory action, which is useful as an agent for the prophylaxis or treatment of autoimmune diseases, inflammatory diseases and the like, in particular, systemic lupus erythematosus, Sjogren's syndrome, rheumatoid arthritis, psoriasis, inflammatory bowel disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.

PYRROLO[3,2-C]PYRIDINE DERIVATIVES AS TLR INHIBITORS

The present invention provides a heterocyclic compound having a TLR7, TLR9, TLR7/8, TLR7/9 or TLR7/8/9 inhibitory action, which is useful as an agent for the prophylaxis or treatment of autoimmune diseases, inflammatory diseases and the like, in particular, systemic lupus erythematosus, Sjogren's syndrome, rheumatoid arthritis, psoriasis, inflammatory bowel disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.

PYRIMIDINES AS KINASE INHIBITORS

Compounds of formula (I) in free or salt or solvate form, where T1, T2, and T3 have the meanings as indicated in the specification, are useful for treating inflammatory or obstructive airways, pulmonary hypertension, pulmo

ORGANIC COMPOUNDS

Compounds of formula (I) in free or salt or solvate form, where T1, T2, X, Ra, Rb, R8 and R9 have the meanings as indicated in the specification, are useful for treating inflammatory or obstructive airways, pulmonary hypertension, pulmonary fibrosis, liver fibrosis, muscle diseases and systemic skeletal disorders. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.